In addition, estrogen signaling increases proliferation of breast cancer cells by upregulating expression of cell cycle enhancers (e.g., cyclin D1) and transcription factors (e.g., c-myc and E2F) expression in breast cancer [19], [20]. Here, CCND1 is linked to breast cancer.